Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Adherens junction 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
2 Adipocytokine signaling pathway 💬
[3] CPT1A, CPT1B, CPT1C 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
3 Adipocytokine signaling pathway 💬
[3] CPT1A, CPT1B, CPT1C 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
4 Adrenergic signaling in cardiomyocytes 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
5 Adrenergic signaling in cardiomyocytes 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
6 Alcoholic liver disease 💬
[3] CPT1A, CPT1B, CPT1C 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
7 Alcoholic liver disease 💬
[3] CPT1A, CPT1B, CPT1C 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
8 Aldosterone synthesis and secretion 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
9 Aldosterone synthesis and secretion 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
10 Alzheimer disease 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
11 Alzheimer disease 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
12 Amphetamine addiction 💬
[2] CACNA1C, CACNA1D 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
13 Amphetamine addiction 💬
[2] CACNA1C, CACNA1D 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
14 AMPK signaling pathway 💬
[3] CPT1A, CPT1B, CPT1C 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
15 AMPK signaling pathway 💬
[3] CPT1A, CPT1B, CPT1C 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
16 Arrhythmogenic right ventricular cardiomyopathy 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
17 Arrhythmogenic right ventricular cardiomyopathy 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
18 Axon guidance 💬
[2] ABL1, SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
19 Bacterial invasion of epithelial cells 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
20 Bladder cancer 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
21 Bladder cancer 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
22 C-type lectin receptor signaling pathway 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
23 Cadherin signaling 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
24 Cadherin signaling 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
25 Cadherin signaling 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
26 Calcium signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
27 Calcium signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
28 cAMP signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
29 cAMP signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
30 Carbohydrate digestion and absorption 💬
[1] CACNA1D 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
31 Carbohydrate digestion and absorption 💬
[1] CACNA1D 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
32 Cardiac muscle contraction 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
33 Cardiac muscle contraction 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
34 Cell cycle 💬
[1] ABL1 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
35 Cellular senescence 💬
[1] CACNA1D 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
36 Cellular senescence 💬
[1] CACNA1D 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
37 cGMP-PKG signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
38 cGMP-PKG signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
39 Chemical carcinogenesis - reactive oxygen species 💬
[2] ABL1, SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
40 Chemical carcinogenesis - receptor activation 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
41 Chemical carcinogenesis - receptor activation 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
42 Chemical carcinogenesis - receptor activation 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
43 Chemokine signaling pathway 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
44 Cholinergic synapse 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
45 Cholinergic synapse 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
46 Chronic myeloid leukemia 💬
[1] ABL1 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
47 Circadian entrainment 💬
[2] CACNA1C, CACNA1D 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
48 Circadian entrainment 💬
[2] CACNA1C, CACNA1D 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
49 Cortisol synthesis and secretion 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
50 Cortisol synthesis and secretion 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
51 Cushing syndrome 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
52 Cushing syndrome 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
53 Cytokine-cytokine receptor interaction 💬
[1] ACVR1 💬 Fidrisertib 💬 Fidrisertib [1] 272 💬
54 Cytokine-cytokine receptor interaction 💬
[1] ACVR1 💬 Zilurgisertib 💬 Zilurgisertib [1] 272 💬
55 Diabetic cardiomyopathy 💬
[2] CPT1B, CPT2 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
56 Diabetic cardiomyopathy 💬
[2] CPT1B, CPT2 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
57 Diabetic cardiomyopathy 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
58 Dilated cardiomyopathy 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
59 Dilated cardiomyopathy 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
60 Dopaminergic synapse 💬
[2] CACNA1C, CACNA1D 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
61 Dopaminergic synapse 💬
[2] CACNA1C, CACNA1D 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
62 Efferocytosis 💬
[3] CPT1A, CPT1B, CPT1C 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
63 Efferocytosis 💬
[3] CPT1A, CPT1B, CPT1C 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
64 Endocytosis 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
65 Epithelial cell signaling in Helicobacter pylori infection 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
66 ErbB signaling pathway 💬
[2] ABL1, SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
67 Estrogen signaling pathway 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
68 Estrogen signaling pathway 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
69 Fatty acid degradation 💬
[4] CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
70 Fatty acid degradation 💬
[4] CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
71 Fluid shear stress and atherosclerosis 💬
[1] ACVR1 💬 Fidrisertib 💬 Fidrisertib [1] 272 💬
72 Fluid shear stress and atherosclerosis 💬
[1] ACVR1 💬 Zilurgisertib 💬 Zilurgisertib [1] 272 💬
73 Fluid shear stress and atherosclerosis 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
74 Fluid shear stress and atherosclerosis 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
75 Focal adhesion 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
76 GABAergic synapse 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
77 GABAergic synapse 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
78 GABAergic synapse 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
79 GABAergic synapse 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
80 GABAergic synapse 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
81 GABAergic synapse 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
82 Gap junction 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
83 Glucagon signaling pathway 💬
[3] CPT1A, CPT1B, CPT1C 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
84 Glucagon signaling pathway 💬
[3] CPT1A, CPT1B, CPT1C 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
85 Glutamatergic synapse 💬
[2] CACNA1C, CACNA1D 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
86 Glutamatergic synapse 💬
[2] CACNA1C, CACNA1D 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
87 GnRH secretion 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
88 GnRH secretion 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
89 GnRH signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
90 GnRH signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
91 GnRH signaling pathway 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
92 Growth hormone synthesis, secretion and action 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
93 Growth hormone synthesis, secretion and action 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
94 Hepatitis B 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
95 Hepatitis B 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
96 Herpes simplex virus 1 infection 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
97 Hormone signaling 💬
[1] ACVR1 💬 Fidrisertib 💬 Fidrisertib [1] 272 💬
98 Hormone signaling 💬
[1] ACVR1 💬 Zilurgisertib 💬 Zilurgisertib [1] 272 💬
99 Hormone signaling 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
100 Human cytomegalovirus infection 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
101 Hypertrophic cardiomyopathy 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
102 Hypertrophic cardiomyopathy 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
103 IgSF CAM signaling 💬
[2] ABL1, SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
104 IL-17 signaling pathway 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
105 Inflammatory mediator regulation of TRP channels 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
106 Insulin resistance 💬
[2] CPT1A, CPT1B 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
107 Insulin resistance 💬
[2] CPT1A, CPT1B 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
108 Insulin secretion 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
109 Insulin secretion 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
110 Integrin signaling 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
111 Kaposi sarcoma-associated herpesvirus infection 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
112 Leukocyte transendothelial migration 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
113 Lipid and atherosclerosis 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
114 Lipid and atherosclerosis 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
115 Long-term potentiation 💬
[1] CACNA1C 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
116 Long-term potentiation 💬
[1] CACNA1C 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
117 MAPK signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
118 MAPK signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
119 MicroRNAs in cancer 💬
[1] ABL1 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
120 MicroRNAs in cancer 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
121 Mitophagy - animal 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
122 Morphine addiction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
123 Morphine addiction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
124 Morphine addiction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
125 Neuroactive ligand signaling 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
126 Neuroactive ligand signaling 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
127 Neuroactive ligand signaling 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
128 Neuroactive ligand-receptor interaction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
129 Neuroactive ligand-receptor interaction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
130 Neuroactive ligand-receptor interaction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
131 Neurotrophin signaling pathway 💬
[1] ABL1 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
132 Neutrophil extracellular trap formation 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
133 Nicotine addiction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
134 Nicotine addiction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
135 Nicotine addiction 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
136 Oxytocin signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
137 Oxytocin signaling pathway 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
138 Oxytocin signaling pathway 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
139 Pathogenic Escherichia coli infection 💬
[2] ABL1, SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
140 Pathways in cancer 💬
[1] ABL1 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
141 Pathways in cancer 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
142 Pathways of neurodegeneration - multiple diseases 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
143 Pathways of neurodegeneration - multiple diseases 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
144 Phagocytosis 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
145 Platelet activation 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
146 PPAR signaling pathway 💬
[4] CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
147 PPAR signaling pathway 💬
[4] CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
148 Prion disease 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
149 Prion disease 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
150 Prolactin signaling pathway 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
151 Prostate cancer 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
152 Proteoglycans in cancer 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
153 Proteoglycans in cancer 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
154 Rap1 signaling pathway 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
155 Ras signaling pathway 💬
[1] ABL1 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
156 Regulation of actin cytoskeleton 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
157 Relaxin signaling pathway 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
158 Relaxin signaling pathway 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
159 Renin secretion 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
160 Renin secretion 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
161 Retrograde endocannabinoid signaling 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
162 Retrograde endocannabinoid signaling 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
163 Retrograde endocannabinoid signaling 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
164 Retrograde endocannabinoid signaling 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam hydrochloride 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
165 Retrograde endocannabinoid signaling 💬
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Midazolam maleate 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
166 Serotonergic synapse 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
167 Serotonergic synapse 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
168 Serotonergic synapse 💬
[3] GABRB1, GABRB2, GABRB3 💬 Midazolam 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
169 Serotonergic synapse 💬
[3] GABRB1, GABRB2, GABRB3 💬 Midazolam hydrochloride 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
170 Serotonergic synapse 💬
[3] GABRB1, GABRB2, GABRB3 💬 Midazolam maleate 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
171 Shigellosis 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
172 Signaling pathways regulating pluripotency of stem cells 💬
[1] ACVR1 💬 Fidrisertib 💬 Fidrisertib [1] 272 💬
173 Signaling pathways regulating pluripotency of stem cells 💬
[1] ACVR1 💬 Zilurgisertib 💬 Zilurgisertib [1] 272 💬
174 Taste transduction 💬
[1] CACNA1C 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
175 Taste transduction 💬
[1] CACNA1C 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
176 Taste transduction 💬
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 Midazolam 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
177 Taste transduction 💬
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 Midazolam hydrochloride 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
178 Taste transduction 💬
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 Midazolam maleate 💬 Midazolam [14]  2 ,  3 ,  6 , 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
179 TGF-beta signaling pathway 💬
[1] ACVR1 💬 Fidrisertib 💬 Fidrisertib [1] 272 💬
180 TGF-beta signaling pathway 💬
[1] ACVR1 💬 Zilurgisertib 💬 Zilurgisertib [1] 272 💬
181 Thermogenesis 💬
[4] CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
182 Thermogenesis 💬
[4] CPT1A, CPT1B, CPT1C, CPT2 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
183 Thyroid hormone signaling pathway 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
184 Tight junction 💬
[1] CACNA1D 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
185 Tight junction 💬
[1] CACNA1D 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
186 Tight junction 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
187 TNF signaling pathway 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
188 Transcriptional misregulation in cancer 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
189 Tuberculosis 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
190 Type II diabetes mellitus 💬
[2] CACNA1C, CACNA1D 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
191 Type II diabetes mellitus 💬
[2] CACNA1C, CACNA1D 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
192 Vascular smooth muscle contraction 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline maleate 💬 Perhexiline [2] 58, 272 💬
193 Vascular smooth muscle contraction 💬
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Perhexiline 💬 Perhexiline [2] 58, 272 💬
194 VEGF signaling pathway 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
195 Viral carcinogenesis 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
196 Viral myocarditis 💬
[1] ABL1 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
197 Yersinia infection 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬